We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of the initial opening bell to start this holiday-shortened week — Friday, July 3rd, will be in observance of Independence Day — we have no new economic reports released. This will change dramatically as the week progresses, from Case-Shiller home prices and Consumer Prices tomorrow to ADP private-sector jobs and ISM Manufacturing and Services Wednesday to Initial Jobless Claims and a new Employment Situation report Friday.
Market futures are up this morning, following a sell-off day Friday on the increase in COVID-19 cases in the U.S. These numbers continue to get worse, as overall cases have hit a new 7-day average high in the U.S., with more than 40K cases reported Sunday and upwards of 50K expected sometime during this week. California, Texas and Florida have now reversed their reopening objectives as cases in those states begin to spiral out of control.
Drug maker Gilead (GILD - Free Report) , which is creating the leading treatment for COVID-19 still being studied in phased testing, has announced its pricing for its treatment remdesivir when it comes to market: $520 per dose for private insurance, $390 for government and other developed countries. This news says nothing about when we might expect to obtain a dose of remdesivir, but these price points are roughly in-line with what analysts had been projecting.
This announcement comes a day after Health and Human Services (HHS) Secretary Alex Azar declared that President Trump has secured half a million courses of remdesivir. Now we can calculate how much this initial buy will cost.
Chesapeake Energy (CHK - Free Report) Files for Chapter 11
Finding difficulties in dealing with its now $10 billion in debt, fracking pioneer Chesapeake Energy (CHK - Free Report) has announced it is filing for Chapter 11 bankruptcy protection. The Oklahoma City, OK-based company — whose founder and CEO Aubrey McClendon was instrumental in bringing the Seattle Supersonics NBA franchise to OK City, which founded the Thunder — was founded in 1989 and taken public in 1993.
Chesapeake was largely considered at the forefront of the at-the-time unconventional hydraulic fracturing (“fracking”) industry, which used immense pressure underground to unlock massive natural gas reserves. The company’s stock hits its apex in late June 2008, when its share price skyrocketed to $12,818 amid all-time high worldwide energy prices.
In the spring of 2016, one day after he had been indicted by a grand jury for rigging bids for oil and gas leases, McClendon died in a single-car crash in OK City. Since that time, Chesapeake has been on a slow but persistent drift downward. Its share price, now at $11.85, is down 97% over the past year. For more on this story, click here.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chesapeake Energy Files Chapter 11
Ahead of the initial opening bell to start this holiday-shortened week — Friday, July 3rd, will be in observance of Independence Day — we have no new economic reports released. This will change dramatically as the week progresses, from Case-Shiller home prices and Consumer Prices tomorrow to ADP private-sector jobs and ISM Manufacturing and Services Wednesday to Initial Jobless Claims and a new Employment Situation report Friday.
Market futures are up this morning, following a sell-off day Friday on the increase in COVID-19 cases in the U.S. These numbers continue to get worse, as overall cases have hit a new 7-day average high in the U.S., with more than 40K cases reported Sunday and upwards of 50K expected sometime during this week. California, Texas and Florida have now reversed their reopening objectives as cases in those states begin to spiral out of control.
Drug maker Gilead (GILD - Free Report) , which is creating the leading treatment for COVID-19 still being studied in phased testing, has announced its pricing for its treatment remdesivir when it comes to market: $520 per dose for private insurance, $390 for government and other developed countries. This news says nothing about when we might expect to obtain a dose of remdesivir, but these price points are roughly in-line with what analysts had been projecting.
This announcement comes a day after Health and Human Services (HHS) Secretary Alex Azar declared that President Trump has secured half a million courses of remdesivir. Now we can calculate how much this initial buy will cost.
Chesapeake Energy (CHK - Free Report) Files for Chapter 11
Finding difficulties in dealing with its now $10 billion in debt, fracking pioneer Chesapeake Energy (CHK - Free Report) has announced it is filing for Chapter 11 bankruptcy protection. The Oklahoma City, OK-based company — whose founder and CEO Aubrey McClendon was instrumental in bringing the Seattle Supersonics NBA franchise to OK City, which founded the Thunder — was founded in 1989 and taken public in 1993.
Chesapeake was largely considered at the forefront of the at-the-time unconventional hydraulic fracturing (“fracking”) industry, which used immense pressure underground to unlock massive natural gas reserves. The company’s stock hits its apex in late June 2008, when its share price skyrocketed to $12,818 amid all-time high worldwide energy prices.
In the spring of 2016, one day after he had been indicted by a grand jury for rigging bids for oil and gas leases, McClendon died in a single-car crash in OK City. Since that time, Chesapeake has been on a slow but persistent drift downward. Its share price, now at $11.85, is down 97% over the past year. For more on this story, click here.